Home > Insider Trading > Filing (0001415889-24-027187)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1109354	Bruker Corp	BRKR	Laboratory Analytical Instruments (3826)	043110160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1133649	H Frank Laukien	C/O Bruker Corporation 40 Manning Road Billerica MA 01821	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-11-18	69,866	$49.82	38,409,429	No	4	P	Direct
Common Stock	Acquisiton	2024-11-18	26,551	$50.82	38,435,980	No	4	P	Direct
Common Stock	Acquisiton	2024-11-18	3,583	$51.36	38,439,563	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	492	Indirect	By Former Spouse
Common Stock	337,087	Indirect	By Son
Common Stock	336,607	Indirect	By Daughter
Common Stock	201,702	Indirect	As UTMA Custodian for Son
Common Stock	71,728	Indirect	As UTMA Custodian for Son
Common Stock	492	Indirect	By Former Spouse

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.30 to $50.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.30 to $51.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $51.30 to $51.48, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1), (2) and (3) of this filing.